StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

AXIM Biotechnologies's free cash flow for the twelve months ending Dec 31, 2023 was -$1.03M. For fiscal 2023 it was -$1.03M. The highest annual figure on record is -$339.00K in fiscal 2014.

Annual free cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$1.03M–
FY2022Dec 31, 2022-$2.05M–
FY2021Dec 31, 2021-$2.53M–
FY2020Dec 31, 2020-$3.31M–
FY2016Dec 31, 2016-$1.29M–
FY2015Dec 31, 2015-$1.52M–
FY2014Dec 31, 2014-$339.00K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2024Mar 31, 2024-$255.35K–
Q4 FY2023Dec 31, 2023$19.56K–
Q4 FY2022Dec 31, 2022-$315.51K–
Q3 FY2022Sep 30, 2022-$323.94K–
Q4 FY2021Dec 31, 2021-$813.41K–
Q4 FY2016Dec 31, 2016-$532.45K–
Q4 FY2015Dec 31, 2015-$385.22K–
Q4 FY2014Dec 31, 2014-$288.68K–

More AXIM Biotechnologies figures

See a number that looks wrong?